Quantcast

New type of allergy medication hits the market - WCAX.COM Local Vermont News, Weather and Sports-

New type of allergy medication hits the market

Posted: Updated:

Spring has sprung in all of its glory in South Texas. That means flowers in bloom, green grass, leaves on the trees and of course pollen. Lots of pollen. Seasonal allergies send people to the doctor's office looking for relief.

For about the last decade, nasal steroids came in a wet form only. The dry versions were phased out when chlorofluorocarbon propellants were banned, blamed for harming the ozone layer.

"And as a result of that, there was a certain demand by the patient who preferred the dry spray," said San Antonio allergy specialist Dr. Paul Ratner. "They felt that it was more palatable. It doesn't have the smell and the odor. It didn't drip down their throat like some of the wet sprays did."

Now, there's a dry nasal steroid hitting the market. QNASL uses a new kind of propellant.

Ratner helped conduct the clinical trials.

"It contains a steroid called beclomethasone and it's taken two sprays in each nostril one time per day," he explained. "I think in terms of patient preference, it will fill a definite unmet need among patients who prefer this type of spray."

QNASL hits store shelves this month. It joins the $2.5 billion market for nasal steroids.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WCAX. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.